← Leaderboards
Katrine Whiteson
University Of California-Irvine
$213,742
Attributed
$427,483
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $238.7K · FY2020–21$250K$187.5K$125K$62.5K$0
'20
'21
Funding mix
By agency
NIH$427,483 · 1
By mechanism
R21$427,483 · 1
Top collaborators
- David Tevis Pride2 shared
Most similar at University Of California-Irvine
Same institution · by research overlap
- Susan S Huang$35,827,644
- Ashlee Miriam Earl$16,638,111
- Bruce Y Lee$13,790,157
- Wei Ling Lau$1,952,475
- Weian Zhao$7,748,750
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsAntibiotic TherapyAntimicrobial ResistanceBacteriaBacterial Antibiotic ResistanceBacterial InfectionsBacterial ResistanceBacteriophagesCarbapenem-Resistant EnterobacteriaceaeCenters For Disease Control And Prevention (U.S.)CharacteristicsClinically RelevantClinical MicrobiologyCollectionCombatCombined AntibioticsCostDesignDrug Resistant PathogenEnterococcusEskape PathogensEvolutionExperimental StudyAntibiotic Resistance